Lorena Galán-Acosta

Author

Lorena Galán-Acosta

Also Known As

L. Galan-Acosta, Lorena Galan-Acosta, Lorena Galán-Acosta

Publications

262

Citations

H-Index

Concepts

All Affiliations

Lorena Galán-Acosta is an author at Karolinska Institutet specializing in medicine, neuroprotection, and cell biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	66
2	Cell Biology	2	2	33
3	Social Sciences	1	1	22
4	Biomolecular Engineering	1	1	22
5	Neurology	1	1	33

Lorena Galán-Acosta

Publications

222

Citations

H-Index

Page 1

	Year	Citations
Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death Hongguang Xia, Ayaz Najafov, Jiefei Geng, The Journal of Cell Biology	2015	121
Intravenous treatment with a molecular chaperone designed against β-amyloid toxicity improves Alzheimer’s disease pathology in mouse models Shaffi Manchanda, Lorena Galán-Acosta, Axel Abelein, Molecular Therapy β-Amyloid ToxicityNeurochemical BiomarkersAβ42 Oligomer GenerationNeuroinflammationAlzheimer's Disease	2022	33
Recombinant BRICHOS chaperone domains delivered to mouse brain parenchyma by focused ultrasound and microbubbles are internalized by hippocampal and cortical neurons Lorena Galán-Acosta, Carlos Sierra, Axel Leppert, Molecular and Cellular Neuroscience Brichos DomainsCellular NeurobiologySocial SciencesNeuroinflammationAlzheimer's Disease	2020	22
Blood–brain and blood–cerebrospinal fluid passage of BRICHOS domains from two molecular chaperones in mice Simone Tambaro, Lorena Galán-Acosta, Axel Leppert, Journal of Biological Chemistry	2019	21
Amyloid-β Peptide Targeting Peptidomimetics for Prevention of Neurotoxicity Dmytro Honcharenko, Alok Juneja, Firoz Roshan, ACS Chemical Neuroscience	2019	14
Glucose metabolism provide distinct prosurvival benefits to non-small cell lung carcinomas Rongrong Wu, Lorena Galán-Acosta, Erik Norberg Biochemical and Biophysical Research Communications OncologyGlucose MetabolismMedicinePathologyDistinct Prosurvival Benefits	2015	11

Page 1